Guggenheim Capital’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.06M Buy
19,208
+303
+2% +$16.7K 0.01% 867
2025
Q1
$914K Sell
18,905
-173
-0.9% -$8.37K 0.01% 912
2024
Q4
$736K Buy
19,078
+11,180
+142% +$432K 0.01% 1068
2024
Q3
$355K Buy
+7,898
New +$355K ﹤0.01% 1539